肩袖修复中结构增强可降低再撕裂风险:系统综述与Meta分析
该系统综述与Meta分析纳入24项研究(12项随机对照试验和12项队列研究),比较结构增强与标准肩袖修复在全层肩袖撕裂患者中的临床与影像学结局。结构增强使再撕裂风险降低35%(风险比0.65,95%CI 0.48-0.89,P=0.01),其中同种异体移植物增强的再撕裂率降低最明显(风险比0.34,95%CI 0.21-0.56),但患者报告结局无显著差异。
要点
- 结构增强使肩袖修复后再撕裂风险降低35%(风险比0.65,95%CI 0.48-0.89,P=0.01)。
- 同种异体移植物增强的再撕裂率降低最明显(风险比0.34,95%CI 0.21-0.56)。
- 疼痛评分、ASES评分和Constant评分等患者报告结局无显著差异。
核心结论
- 肩袖修复中结构增强显著降低再撕裂率,尤其是同种异体移植物增强,但不改善短期患者报告结局。
研究设计与样本
- 系统综述与Meta分析,证据等级3级。
- 纳入24项研究,包括12项随机对照试验和12项队列研究,均评估生物增强(异种移植物、同种异体移植物、自体移植物)。
- 检索CENTRAL、Embase和Medline,从建库至2024年11月13日。
- 采用Cochrane随机对照试验偏倚风险工具和MINORS评分评估偏倚风险。
- 采用随机效应模型进行Meta分析,并按研究设计和增强类型进行亚组分析。
主要发现
- 与标准肩袖修复相比,结构增强显著降低再撕裂风险35%(风险比0.65,95%CI 0.48-0.89,P=0.01),再撕裂经磁共振成像或超声影像学确认。
- 亚组分析显示同种异体移植物增强的再撕裂率降低最明显(风险比0.34,95%CI 0.21-0.56)。
- 患者报告结局包括疼痛评分、美国肩肘外科医师(ASES)评分和Constant评分均无显著差异。
关键数值与推荐
- 结构增强 vs 标准肩袖修复:再撕裂风险比0.65(95%CI 0.48-0.89,P=0.01)。
- 同种异体移植物增强亚组:再撕裂风险比0.34(95%CI 0.21-0.56)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以确定哪些患者和撕裂特征可能影响增强的有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rotator cuff tears are a common orthopaedic injury often resulting in shoulder pain and functional impairment. Despite the prevalence of rotator cuff tears, the incidence of retear after rotator cuff repair (RCR) remains high. There is growing interest in the use of structural augmentation in RCR to decrease retear rates and improve patient outcomes. PURPOSE: The purpose of this systematic review and meta-analysis was to compare the clinical and imaging outcomes of structural augmentation versus standard RCR in patients with full-thickness rotator cuff tears. The effectiveness of different augment subtypes was also assessed. STUDY DESIGN: Meta-analysis; Level of evidence, 3. METHODS: A comprehensive literature search was conducted in CENTRAL, Embase, and Medline from inception to November 13, 2024. Eligible studies included comparative trials evaluating structural augmentation in RCR for repairable full-thickness tears. Risk of bias was assessed using the Cochrane risk-of-bias tool for randomized controlled trials and the MINORS (Methodological Index for Non-randomized Studies) score for observational studies. Meta-analyses were performed via a random effects model, with subgroup analyses performed by study design and augment type. RESULTS: Twenty-four studies (12 randomized controlled trials and 12 cohort studies) were included in this review, all of which evaluated biologic augments (xenograft, allograft, autograft). Structural augmentation significantly reduced the risk of retear by 35% as compared with standard RCR (risk ratio, 0.65; 95% CI, 0.48-0.89; P = .01). Retears were confirmed radiographically by magnetic resonance imaging or ultrasound. Subgroup analysis revealed the greatest reduction in retear rates with allograft augmentation (risk ratio, 0.34; 95% CI, 0.21-0.56). No significant differences were observed in patient-reported outcomes, including pain scores, American Shoulder and Elbow Surgeons scores, or Constant scores. CONCLUSION: Structural augmentation in RCR significantly reduces retear rates, particularly with allografts, but does not improve short-term patient-reported outcomes. Further research is needed to identify which patient and tear characteristics may influence the effectiveness of augmentation.
引用
- Dagher D, Shah D, Kruse C, et al. Structural Augmentation in Rotator Cuff Repair Decreases the Risk of Retear: A Systematic Review and Meta-analysis. Am J Sports Med. 2026. PMID: 41549444. doi:10.1177/03635465251400356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。